Study FFR116364, a Placebo-controlled Study of GW685698X in Paediatric Subjects With Perennial Allergic Rhinitis
Status:
Completed
Trial end date:
2012-08-01
Target enrollment:
Participant gender:
Summary
Efficacy and safety of GW685698X (55 µg/day, q.d.) nasal spray over a period of 2 weeks in
Japanese paediatric subjects ages 6 to < 15 years with perennial allergic rhinitis will be
evaluated compared with placebo.